Management Committee

Christopher Rowe

Director

Prof Rowe BMBS, FRACP, MD, FAANMS is a nuclear medicine physician and neurologist, with over 20 years of experience in dementia research and patient care. He is the Director of Molecular Imaging Research at Austin Health, Melbourne, Professorial Fellow University of Melbourne, a NHMRC Practitioner Fellow and is the inaugural Director of the Australian Dementia Network. His research focus is molecular imaging of neurodegenerative diseases, particularly AD, for better understanding, earlier more accurate detection, and to facilitate development of early therapeutic interventions. He has over 300 publications and is in the 2018 Highly Cited Researcher list of the top 1% world-wide for neuroscience and has received the 2011 US Society of Nuclear Medicine Kuhl-Lassen Award for Outstanding Contribution to Brain Imaging and the 2016 Christopher Clark Award for advancing human amyloid imaging.

Perminder Sachdev

Deputy Director

Prof Sachdev AM MBBS MD FRANZCP PhD FAHMS is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 600 peer-reviewed journal papers and 6 books, including one for lay readers (The Yipping Tiger and other tales from the neuropsychiatric clinic) and a book of poems (A migrant’s musings). He was named NSW Scientist of the year for Biomedical Sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research.

Stephanie Ward

Clinical Quality Registry Lead

Dr Ward BMed FRACP MPH is a practising geriatrician based at the Prince of Wales Hospital, Sydney, experienced in the diagnosis and care of persons living with dementia and cognitive impairment in a variety of settings and was involved in establishing the pilot dementia clinical quality registry project at Monash University. She leads clinician engagement with the ADNet Registry.

Sharon Naismith

Memory Clinics Lead

Prof Naismith is a Clinical Neuropsychologist, NHMRC Dementia Leadership Fellow and Heads the Healthy Brain Ageing Program at the Brain and Mind Centre. Her work focuses on modifiable risk factors for dementia and clinical interventions for early cognitive decline including cognitive training, sleep and pharmacological interventions. She leads an NHMRC Centre of Research Excellence to ‘Optimise Sleep in Brain Ageing and Neurodegeneration (CogSleep).

Colin Masters

Trials Lead

Prof Masters' career over the last 35 years is widely acknowledged as having had a major influence on Alzheimer’s disease research worldwide, particularly the collaborative studies conducted with Konrad Beyreuther in which they discovered the proteolytic neuronal origin of the Aβ amyloid protein which causes Alzheimer’s disease. More recently, his focus has been on describing the natural history of Alzheimer’s disease as a necessary preparatory step for therapeutic disease modification. His achievements have been recognised by the receipt of many international awards.

Michael Breakspear

Technology Lead

Prof Breakspear MB BS, PhD, FRANZCP is a professor of neuroscience at the University of Newcastle and a consultant psychiatrist. He runs a research program of computational and translational neuroimaging. He is lead CI of the technological arm of ADNeT.

Peter Schofield

Business Lead

Prof Schofield AO FAHMS PhD DSc is CEO of NeuRA (Neuroscience Research Australia) and a Professor of Medicine at UNSW. His research interests focus on genetics of brain function, neurodegenerative and psychiatric disorders such as Alzheimer's disease and bipolar disorder. He is a site leader for the Dominantly Inherited Alzheimer Network. He served as the Interim Director of the NNIDR in 2016-17.

Cherry Ann Santos

Operations Manager

With more than 15 years' experience in program and project management roles in Australia and Asia, Cherry brings a strategic, proactive and people-oriented approach to ADNeT. Prior to joining ADNeT, Cherry led the development of key infrastructure projects for the Faculties of Science, Engineering, Medicine, and Architecture of the University of Melbourne. She also has extensive consulting experience with the Asian Development Bank on various regional cooperation projects across Asia. Cherry holds a Master of Development Economics and a Master of Management.

Larry Ward

Business Manager

Dr Ward is a highly experienced biotechnology executive with over 20 years’ experience in the biotechnology industry at companies including AMRAD, Virax Holdings and Medicines Development for Global Health (MDGH) in positions spanning from Laboratory Director through to CEO. Dr. Ward heads the business development function within ADNeT as well as in the related organisations AIBL and CRC for Mental Health.

Clinical Investigators

Christopher Rowe

University of Melbourne

Prof Rowe BMBS, FRACP, MD, FAANMS is a nuclear medicine physician and neurologist, with over 20 years of experience in dementia research and patient care. He is the Director of Molecular Imaging Research at Austin Health, Melbourne, Professorial Fellow University of Melbourne, a NHMRC Practitioner Fellow and is the inaugural Director of the Australian Dementia Network. His research focus is molecular imaging of neurodegenerative diseases, particularly AD, for better understanding, earlier more accurate detection, and to facilitate development of early therapeutic interventions. He has over 300 publications and is in the 2018 Highly Cited Researcher list of the top 1% world-wide for neuroscience and has received the 2011 US Society of Nuclear Medicine Kuhl-Lassen Award for Outstanding Contribution to Brain Imaging and the 2016 Christopher Clark Award for advancing human amyloid imaging.

Perminder Sachdev

University of New South Wales

Prof Sachdev AM MBBS MD FRANZCP PhD FAHMS is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 600 peer-reviewed journal papers and 6 books, including one for lay readers (The Yipping Tiger and other tales from the neuropsychiatric clinic) and a book of poems (A migrant’s musings). He was named NSW Scientist of the year for Biomedical Sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research.

Stephanie Ward

University of New South Wales

Dr Ward BMed FRACP MPH is a practising geriatrician based at the Prince of Wales Hospital, Sydney, experienced in the diagnosis and care of persons living with dementia and cognitive impairment in a variety of settings and was involved in establishing the pilot dementia clinical quality registry project at Monash University. She leads clinician engagement with the ADNet Registry.

Sharon Naismith

University of Sydney

Prof Naismith is a Clinical Neuropsychologist, NHMRC Dementia Leadership Fellow and Heads the Healthy Brain Ageing Program at the Brain and Mind Centre. Her work focuses on modifiable risk factors for dementia and clinical interventions for early cognitive decline including cognitive training, sleep and pharmacological interventions. She leads an NHMRC Centre of Research Excellence to ‘Optimise Sleep in Brain Ageing and Neurodegeneration (CogSleep).

Colin Masters

University of Melbourne

Prof Masters' career over the last 35 years is widely acknowledged as having had a major influence on Alzheimer’s disease research worldwide, particularly the collaborative studies conducted with Konrad Beyreuther in which they discovered the proteolytic neuronal origin of the Aβ amyloid protein which causes Alzheimer’s disease. More recently, his focus has been on describing the natural history of Alzheimer’s disease as a necessary preparatory step for therapeutic disease modification. His achievements have been recognised by the receipt of many international awards.

Michael Breakspear

University of Newcastle

Prof Breakspear MB BS, PhD, FRANZCP is a professor of neuroscience at the University of Newcastle and a consultant psychiatrist. He runs a research program of computational and translational neuroimaging. He is lead CI of the technological arm of ADNeT.

Susannah Ahern

Monash University

Prof Ahern MBBS (Hons), MBA, FRACMA, PhD, is the Head of the Registry Sciences Unit, Monash University Department of Public Health and Preventative Medicine. She has extensive experience in the development and management of clinical quality registries and brings this experience and the IT facilities of Monash University that are essential for the successful development and implementation of the national Dementia CQR.

Kaarin Anstey

NeuRA

Prof Anstey BA (Hons) Syd., PhD Qld., FASSA, FAPS is a Scientia Professor and Director of the UNSW Ageing Futures Institute, and a Senior Principal Research Scientist at NeuRA. She leads an NHMRC Centre of Research Excellence in Cognitive Health, is a director of the NHMRC Dementia Centre for Research Collaboration and Co-Deputy Director of the ARC Centre of Excellence in Population Ageing Research.

Henry Brodaty

University of New South Wales

Prof Brodaty AO, MB BS, MD, DSc, FRACP, FRANZCP, FAHMS is a researcher, clinician, policy advisor and strong advocate for people with dementia and their carers. At UNSW Sydney, he is Scientia Professor of Ageing and Mental Health, Co-Director of the Centre for Healthy Brain Ageing, and Director, Dementia Centre for Research Collaboration. He has over 500 publications in refereed journals, is senior psychogeriatrician and Head of the Memory Clinic at POW Hospital. He was previously President of International Psychogeriatric Association, Chairman of Alzheimer’s Disease International, and President of Alzheimer’s Australia NSW and Australia. He is an officer of the Order of Australia and Ryman Prize winner.

Ralph Martins

ECU

Prof Martins holds a joint academic appointment – Foundation Professor and Inaugural Chair in Ageing and Alzheimer’s (Edith Cowan University) and Professor in Biomedical Sciences (Macquarie University). His groundbreaking discoveries include the seminal discovery of beta-amyloid and its precursor, the amyloid precursor protein (APP), found in the brains of Alzheimer’s patients which is now universally acknowledged as being fundamental to the molecular pathology of Alzheimer’s disease.

James Vickers

University of Tasmania

Prof Vickers is the Director of the Wicking Dementia Centre. His main research areas are in neurodegenerative conditions, particularly Alzheimer’s disease, as well as neural injury and plasticity. His research extends from human brain research through to experimental models and interventional cohort studies.

Associate Investigators

Peter Schofield

NeuRA

Prof Schofield AO FAHMS PhD DSc is CEO of NeuRA (Neuroscience Research Australia) and a Professor of Medicine at UNSW. His research interests focus on genetics of brain function, neurodegenerative and psychiatric disorders such as Alzheimer's disease and bipolar disorder. He is a site leader for the Dominantly Inherited Alzheimer Network. He served as the Interim Director of the NNIDR in 2016-17.

Rob Grenfell

CSIRO

Dr Grenfell, a Public Health Physician, is the Director of CSIRO’s Health and Biosecurity Business Unit. Leading a broad portfolio covering Nutrition, eHealth, Medtech and Diagnostics and Biosecurity from weeds to Ebola. Rob has broad ranging public health experience including the National Medical Director at BUPA Australia New Zealand, National Director Cardiovascular Health at the Heart Foundation, Strategic Health Advisor to Parks Victoria, Senior Medical Advisor at the Department of Health Victoria, Physician in charge of travel health BHP and General Practice. He was a member of the Safety and Quality Outcomes Committee of the Hospital Innovation Reform Council, a member of the Victorian Quality Council, Chair of General Practice Victoria, and Member of the Health Advisory Committee of the National Health and Medical Research Council.

Susan Kurrle

University of Sydney

Prof Kurrle is a geriatrician practising in northern Sydney and in southern NSW. She has had a longstanding interest in diagnosis and management of dementia. She holds the Curran Chair in Health Care of Older People in the Faculty of Medicine and Health at the University of Sydney, where she has led the NHMRC Cognitive Decline Partnership Centre since 2012.

Elizabeth Beattie

Queensland University of Technology

Elizabeth Beattie PhD, RN, FGSA, FAAN, Professor of Aged and Dementia Care, School of Nursing, Queensland University of Technology, is a psychogeriatric nurse educated in Australia, the UK and the US who has been involved in dementia-focused clinical practice, education and research for 30 years. She is a Director of the Dementia Centre for Research Collaboration and Dementia Training Australia. Elizabeth has an international nursing leadership profile and a sustained record of competitive research funding and publication. Her research is focused on improving the quality of care and quality of life of people living with dementia and those who support them.

Ashley Bush

The Florey Institute of Neuroscience and Mental Health

Prof Bush MBBS, DPM, FRANZCP, PhD, FAAHMS, FAPA is NHMRC Senior Principal Research Fellow and the Director of the Melbourne Dementia Research Centre at The Florey Institute of Neuroscience & Mental Health, University of Melbourne. He has experience in prospective cohorts for dementia biomarker and imaging development, as well as dementia clinical trials, that will be used to optimize the value of the ADNeT registries.

Maria Crotty

Flinders University

Prof Crotty is a Rehabilitation Physician and Clinical Academic at Flinders University. She is Director of Rehabilitation at Flinders Medical Centre and a Research Fellow at the South Australian Health and Medical Research Institute. She leads a multidisciplinary research group who focus on how to implement best and promising care models and practices within health and aged care settings. She has undertaken many projects in residential aged care settings with people who have dementia. She has a research interest in non pharmacological approaches after dementia diagnosis.

Annette Dobson

University of Queensland

Prof Dobson AM, FAHMS, BSc, MSc, PhD, Grad Cert Mngt, A Stat is Professor of Biostatistics and Director of the Centre for Longitudinal and Life Course Research in the School of Public Health at the University of Queensland. She has expertise running large scale, long duration, epidemiological studies in cardiovascular disease and women’s health, statistical methodology and modelling.

Leon Flicker

University of Western Australia

Leon Flicker is the inaugural Professor of Geriatric Medicine at the University of Western Australia since 1998. He helped establish a research unit aimed at translational issues focusing on the health needs of older people, the Western Australian Centre for Health and Ageing. He has been interested in the risk factors, assessment and management of the common problems of older people. In 2017 he was honored with an Order of Australia for his contributions to geriatric medicine and dementia prevention and care.

Paul Maruff

University of Melbourne

Paul Maruff PhD is Chief Science Officer at CogState Ltd, Australia and Professor at Florey Institute for Neuroscience.

John McNeil

Monash University

Prof McNeil MSc PhD FRACP is a physician/epidemiologist whose principal interest has been clinical quality registries and clinical trials. He is the co- Principal Investigator of the ASPREE (ASPirin in Reducing Events in the Elderly) study.

Peter Nestor

University of Queensland

Prof Nestor is conjoint professor of cognitive neurology at the University of Queensland and the Mater Hospital. He trained in neurology in Melbourne and London in the 90s then worked for several years as a clinician-scientist at the University of Cambridge. From 2012 until returning to Australia in 2017, he was Professor of Cognitive Neurology at the German Center for Neurodegenerative Diseases.

Olivier Salvado

University of Queensland

Prof Salvado MSEE, MBA, PhD, is the Head of Imaging and Computer Vision at CSIRO Data61 and Honorary Professor with QUT and UQ. He has been involved in several large clinical studies involving medical image setup and analysis (MRI and PET) and biostatistics, including the AIBL and PISA studies. Prof Salvado has active research interest in AI applications for precision medicine and is involved in several multidisciplinary image analysis projects.